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Abstract: Hepatitis C (HCV) is a virus characterized by an RNA-dependent RNA polymerase 
that lacks a proofreading mechanism and, as a result, generates a quasispecies. There is emerging 
evidence that this RNA-dependent RNA polymerase may in fact have variable fidelity. Here, 
we review the relevant concepts, including fitness landscapes, clonal interference, robustness, 
selection, adaptation, mutation rates, and their optimization, and provide a unique interpretation 
of a number of relevant theoretical models, evolving the theory of replicative homeostasis in 
light of their findings. We suggest that a variable fidelity polymerase can find its own optimal 
mutation rate, which is governed by the sequence itself and certain population dynamics. We 
propose that this concept can explain features of viral kinetics and clearance, both spontane-
ously and following treatment of chronic HCV. We point to evidence that supports this theory 
and explain how it refines replicative homeostasis and conclude by discussing particular areas 
of potential research that might augment our understanding of viral host interactions at an 
individual cellular level.
Keywords: fitness landscapes, adaptation, evolution, quasispecies, hepatitis C, replicative 
homeostasis
Introduction
Hepatitis C (HCV), a positive 9.2–9.6 kb RNA Flavivirus, was first identified by 
Choo and colleagues at Chiron in 1989 and is estimated to infect up to 3% people 
worldwide, equivalent to 120–170 million people.1–3 Chronic HCV infection leads to 
the development of cirrhosis in 20% of cases after 20 years and is now the leading 
indication for orthoptic liver transplantation in the USA.
Low fidelity and the lack of proofreading ability of the HCV RNA-dependent RNA 
polymerase (RDRP) results in a population of closely related genomes or quasispecies.4 
Originally proposed by Eigen as a model for the study of the evolution of primitive 
organisms, the quasispecies concept has been applied to many bacteria and viruses 
including human immunodeficiency virus and HCV.5 The gradual generation of point 
mutations results in the development of new variant species or “quasispecies” with 
slightly altered characteristics that then undergo selection. Within a given host, those 
quasispecies best adapted to the environment are most likely to survive and become 
dominant as a result of the principle of competitive exclusion.6 The most prevalent 
quasispecies is the “master” sequence and other related quasispecies cluster around 
this in terms of their genetic distance. Mutations either undergo selection (positive, 
resulting in the selection of beneficial traits; negative, when a deleterious trait is 
removed). Alternatively, in the absence of selection, the gradual accumulation of 
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neutral or near neutral mutations of insufficient magnitude 
to prompt selection results in an evolutionary process known 
as “genetic drift.” Gradual adaptation to the host occurs as a 
result of these processes with the neutral theory of evolution 
predicting that genetic drift will be the predominant form of 
evolution.7 For a mutation to provoke a change from genetic 
drift to natural selection it must breach what has been termed 
the “selection threshold.”8
These processes are dependent on a number of factors 
including virion fitness, population size, clonal density, 
clonal interference, and mutation rates. Our understand-
ing of HCV has grown exponentially as a result of both 
experimental results and mathematical modeling, which have 
facilitated better understanding of viral replication processes 
and, as a result, viral genomic selection, adaptation, and 
evolution. This review provides an up-to-date appraisal of 
these topics.
Fitness
Conceptually, each genome has an inherent fitness defined by 
a group of characteristics (ability to infect, ability to replicate, 
energy requirement), with each quasispecies competing for 
host resources (host cells, cellular machinery, etc). Within the 
population, each sequence competes for these host resources 
with the best adapted, or fittest characteristics, most likely to 
dominate. However, the transience of this domination is guar-
anteed by the mechanism by which it is generated; the almost 
inexorable emergence of fitter mutants demands continual 
evolution for survival, in a process called the “Red Queen 
Hypothesis.”9 A moderate increase in viral fitness of one qua-
sispecies over another results in exponential proliferation of 
this new quasispecies, with likely extinction of its competitor 
sequences in what amounts to a zero-sum game.10
Fitness landscapes
Viral fitness can be described in the form of a fitness land-
scape, with mountains corresponding to areas of increased 
fitness surrounded by areas of diminishing fitness analogous 
to foothills (Figure 1). The accumulation of mutations allows 
the exploration of the sequence space and through this process 
the discovery of fitness gains that might displace the master 
sequence through competition. In the case of HCV, because 
the number of possible nucleotide combinations is so great 
(49.600), this landscape is only able to describe quasispecies 
diversity for short segments of the sequence. Not all muta-
tions are viable, with these lethal mutations akin to cliffs in 
what is known as a “truncated fitness landscape.” Finally, the 
combined interplay between individual quasispecies and the 
immune system results in a changing or dynamic truncated 
fitness landscape.
In this setting, the lack of a proofreading function is 
often looked upon as beneficial to HCV; adapted mutants, 
which are closely related to the parent virion and better able 
to evade the host’s immune response, emerge and maintain 
chronic infection. However, in this model the proviso is 
that high mutation rates mean that beneficially adapted 
mutants are equally prone to deleterious mutations, which 
can potentially wipe out entire quasispecies. Muller’s 
ratchet predicts that deleterious mutations are likely to 
“hitchhike” and be found in all future progeny, barring the 
unlikely event of a reciprocal mutation taking place.11,12 
Mitigating the effects of hitchhiking is the process of 
recombination, which can facilitate the removal of deleteri-
ous mutations by combining mutation-free segments and 
allow greater potential exploration of the sequence space 
by combining sequences with multiple mutations. It is this 
latter process that is thought to contribute significantly to 
the emergence of differing HCV genotypes and even taxa 
and species.13,14
Interference
Although a significant factor in determining the fate of a 
given quasispecies, competitive exclusion is not the sole 
determinant of evolutionary success. In large quasispecies 
populations, it has been shown that sequences with sig-
nificant fitness superiority are not necessarily guaranteed to 
dominate a quasispecies due to a process known as “clonal 
interference.”15–17 In small populations, beneficial mutations 
of smaller increments are more likely to come to dominate 
as a result of selective sweep, while, in large populations 
(as are seen in established chronic HCV infections), a qua-
sispecies with significant fitness benefit can be suppressed 
by the less-fit dominant quasispecies, unless it reaches a 
Local fitness optimaGlobal fitness optimum
Figure 1 Schematic representation of the sequence space in the form of a fitness 
landscape. 
Notes: The accumulation of mutation facilitates the exploration of the landscape. 
Adaptation results in the discovery of local fitness optima and potentially the global 
fitness optimum.
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critical threshold. This has the net effect of ensuring that, in 
chronic infection, the incremental increase in quasispecies 
fitness becomes larger in fitness gain but more infrequent in 
occurrence. Experimental evidence of clonal interference 
supporting this theory has been found in Escherichia coli, 
DNA viruses, HCV, and the RNA vesicular stomatitis virus 
(VSV).16,18–21
Defective interfering particles
Notwithstanding the extreme variability seen in the genetic 
sequence of RNA viruses, it must be remembered, how-
ever, that redundancy in the sequence is limited and that the 
proteins produced are small in number and, in most cases, 
essential in function. However, despite this lack of redun-
dancy, subgenomic particles exist that can have significant 
effects on virus population dynamics.
Named “defective interfering particles” (DIPs) and identi-
fied in several virus species (including both DNA and RNA 
viruses), they may be important factors in the search for fitter 
quasispecies resistant to the effects of DIPs.22–26 Unable to 
replicate in the absence of wild-type virus but able to infect 
new cells, they are thought to contribute to the oscillating 
nature of the viral load repeatedly seen in HCV infection. 
DIPs have also been proposed to interfere in the production 
of wild-type virus and modulate pathogen virulence and may 
themselves be potential antiviral agents.27–30
Stumpf and Zitzmann have proposed the reciprocality 
of DIPs; that is, that the particles are able to replicate but 
are unable to cause de novo infection of new cells due to 
the deletion of the structural section of the genome. The 
associated increase in replicative ability leads to competitive 
exclusion of viable virions and the gradual accumulation of 
defective intracellular viral RNA, meaning that continuous 
de novo infection of new cells is essential to viral survival.31 
Experimental evidence for this has remained elusive.
Studies focused on hepatocyte-derived HCV genomic 
sequences have not found evidence of these particles, though 
factors such as the duration of infection and use of limited 
numbers of clones (it is estimated that use of 20 clones 
will demonstrate most sequences present at a level of 10%) 
may go some way to explain this.32–34 Indeed, the advent of 
next-generation sequencing may see the reemergence of 
this concept.
Robustness
The ability of a virion to tolerate mutations without phe-
notypic disruption, termed “robustness,” is also likely 
to be important in maintaining or enhancing f itness. 
Characterized by a greater number of available neutral 
 mutations, a high degree of robustness results in a smoother 
fitness landscape, in a theory described as “survival of the 
flattest.”35 Studies using digital models and subviral particles 
suggest that an organism with greater robustness may out 
compete and dominate less robust counterparts, particularly 
at times of high mutagenesis.35–37
The emergence of neutral mutation-rich organisms may 
however have significant implications for virion evolution. 
A recent study has demonstrated that a high proportion of 
neutral or near-neutral mutations may act as a barrier to 
evolution by natural selection, with genetic drift coming to 
dominate.8 Studies evaluating HCV robustness are limited, 
but one network-based analysis of HCV polyprotein has 
demonstrated a high degree of robustness at many nucle-
otide positions, with relatively few positions vulnerable to 
phenotypically deleterious mutation.38 Comparisons with 
other RNA viruses are challenging, as direct studies have 
not yet been published. One recent paper has estimated by 
site-directed mutagenesis that 40% of random mutations in 
VSV are lethal, which may suggest a lesser degree of robust-
ness compared with HCV.39
Finally, it has been suggested that increased robustness 
may result in a reduced ability to adapt and that, in organisms 
that are required to survive in changing environments, the 
requirement for frequent adaptive change will limit tolerance 
of neutrality/robustness.40 Indeed, the ability of an organ-
ism to respond to selective pressure and tolerate significant 
large-scale genetic evolution or evolvability has also been 
demonstrated as a selectable trait.41
Cooperative interaction
The concept of the “cooperative interaction” of the constituent 
mutants in exploring fitness maxima, so that the population 
ultimately achieves a mutation–selection equilibrium, dis-
tinguishes quasispecies theory from classical population 
genetics. When looked on in this light, it becomes apparent 
that successful quasispecies evolution is a population-wide 
phenomenon, so that fitness can be seen as an “ensemble 
property.”42 While evidence for this phenomenon is limited, 
studies of poliovirus have demonstrated that the pathogenesis 
of individual quasispecies is affected by cooperative interac-
tion with other mutants in the quasispecies profile and that 
maintenance of a degree of heterogeneity is preferable for 
viral survival and maintenance of tissue tropism.43 Indeed, 
the influence of cooperative reactions has been proposed as 
essential if mathematical models are to accurately generate 
the quasispecies patterns observed in vivo.44
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Adaptation
“Adaptation” is the process whereby the quasispecies alters 
to become more suited to new or changing environments. The 
rate of adaptation of quasispecies appears to be governed by 
a number of factors: population size, mutation rate, adaptive 
quotient, and variability of the environment. In small popula-
tions, the size of the population limits the ability to explore 
the sequence space. As a result, adaptation occurs at a slower 
rate by means of stochastic genetic drift with episodic selec-
tive sweeps. This means that the population is more likely to 
be confined to local fitness peaks. In contrast, large popula-
tions are better able to expand throughout the sequence space 
and, as a result, adaptation is more deterministic, though the 
time taken for fixation of beneficial mutations is increased 
as a result of interference.45,46
Mutation rates
The effects of different mutation rates on a quasispecies 
within a truncated fitness landscape appear to follow three 
patterns: (1) low mutation rates result in a distribution 
around the master sequence and are more likely to become 
“trapped” in local fitness peaks, reducing the chances of 
complete exploration of the sequence space; (2) intermediate 
mutation rates result in wider exploration of the sequence 
space, with the emergence of variants further removed 
from the master sequence; and (3) those with high mutation 
rates produce an ever-increasing number of progeny with 
lethal mutations and, as a result, reach what has been called 
the “error threshold” – the point at which the quasispecies 
becomes unable to maintain sequence integrity. The coercion 
of viruses beyond this point into what has been called “error 
catastrophe” has been a major strategy in the development 
of antiviral therapies.46–49
Interestingly, adaptation is not maximal prior to reach-
ing error threshold; rather, it behaves in a sine wave fash-
ion (Figure 2). The mutation rate that results in optimal 
adaptation is remote from error threshold and adaptation 
decreases with increasing mutation rate as the ability to 
fix beneficial mutations decreases until error threshold is 
breached.50,51 Using parameters present in quasispecies, 
Orr has found that optimal mutation rates for adaptation 
are governed by the strength of selection against deleteri-
ous mutations (ie, more truncated landscapes have a lower 
optimal adaptive mutation rate).50 This work was based on 
the assumption that the selective power against deleterious 
mutations was at all times greater that the selective power 
for beneficial mutations; however, this may not, in fact, 
be the case.
Adaptive quotient
Johnson and Barton advanced this theory by describing a 
matrix that can predict a sequence-specific optimal mutation 
rate depending on whether the surrounding fitness landscape 
is dominated by deleterious or beneficial mutations and the 
selective power of these relative to each other.52 According 
to this model, the existence of many potential beneficial 
mutations will promote the emergence of a higher mutation 
rate and vice versa. In the setting of a bottleneck event (rapid 
reduction in quasispecies – as occurs at transmission of HCV) 
the organism can be seen to be less adapted to the new host 
and, as a result, the ratio of beneficial:deleterious mutations 
is also likely to change and will probably be reflected in the 
rate of mutation.53
Variability of environment
In static environments, the exploration of the sequence space 
with fixation of beneficial mutations that pass the selection 
threshold and outlast clonal interference becomes exhausted 
once the quasispecies reaches the mutation–selection 
equilibrium. At this stage, all fitness optima have been 
explored. As this occurs, the fitness gains that were initially 
large, diminish toward nil.54 With many microorganisms, 
however, the emergence of new environments, either as a 
result of transmission of infection or the development of 
immune responses, results in a dynamic fitness landscape that 
serves to replenish the potential for adaptive change.
Furthermore, the ruggedness of these landscapes can 
themselves affect the rate of adaptation. Clune et al demon-
strated using computer models that digital organisms fail to 
optimize mutation rates and tend to settle at a mutation rate 
below this.55 Evidence for this has been described in DNA 
bacteriophages, where the imposition of a fourfold increase 
in mutation rate actually conferred fitness gain.55,56 Clune et al 
argued that, while adaptation occurs over long periods (many 
generations), selection acts quickly and this phenomenon 
Mutation rate
Adaptation
Optimal adaptive 
mutation rate Error threshold
Figure 2 The interaction between mutation rates and the rate of adaptation.
Notes: Beyond the optimal adaptive mutation rate, increasing mutation rates result 
in an ever-diminishing rate of adaptation until the error threshold is reached.
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may be an effort by the virus to mitigate the potential for 
emergence of deleterious/lethal mutations. Expanding on 
this initial finding, Clune et al demonstrated that the observed 
mutation rate is dependent on the ruggedness of the fitness 
landscape with more rugged landscapes favoring an even 
lower mutation rate.55
The fidelity spectrum
There is a growing body of literature indicating that muta-
tion rates are not constant and may be selectable. Mutation 
rates have been shown to increase at times of stress in many 
bacteria and lethal mutagenesis has long been suggested 
as a potential treatment strategy in viral infections.57 The 
beneficial effects of increased mutational rates, in addition 
to how they may be associated with increased replicative 
capacity, have also been demonstrated in bacteriophage 
populations.58 Furthermore, adaptive change in the mutation 
rate in response to medications has been shown to confer 
drug resistance and sustain chronic infection in the case of 
human immunodeficiency virus type 1.59 Several mechanisms 
governing how transient increases in mutation rate can be 
generated and suitably regulated have been suggested, includ-
ing environmental and heritable factors.60
Evidence of variable RDRP  
mutation rates in HCV
In HCV, the estimated mutation rate is 1 × 10-4 to 5/base.61–63 
The estimation of the error threshold of HCV RDRP is 10-2 to 3 
(mutations per base), which leaves scope for a ten- to hun-
dredfold change in baseline RDRP fidelity before the error 
threshold is reached, with the optimal adaptive mutation rate 
likely to be found within this range. Lethal mutagenesis has 
formed one of the theories of the mechanism of action of 
ribavirin, as it has been shown to induce lethal mutagenesis 
in poliovirus and foot-and-mouth disease, but the results 
in HCV have been variable.62,64,65 Ribavirin-resistant muta-
tions have been described, both in vitro and in vivo, in two 
HCV nonstructural proteins (NS5A and NS5B) including 
the RDRP. It has been suggested that the NS5A mutation 
may indicate that this protein may interact with the RDRP 
to modulate polymerase fidelity.62,66,67 Indeed, the idea that 
RDRP fidelity may be controlled remotely is not novel to 
HCV.68
Recently, mutant RDRPs conferring ribavirin resistance 
by means of increased fidelity have been described in both 
foot-and-mouth disease virus and poliovirus. We feel that 
similar mutants are likely to exist in the case of HCV and 
that their emergence during ribavirin therapy would explain 
the heterogeneity of the effect on mutation rates seen in these 
studies. Furthermore, the sampling intervals may have been 
such that transient increases in mutation rates may have 
been missed.
A mechanism by which viruses might self-regulate rep-
lication fidelity has been proposed by Sallie in his theory of 
replicative homeostasis (RH).69–71 Sallie argued that HCV 
viral kinetics behave in such a way to suggest autoregulation 
of virion production through a homeostatic mechanism that 
modulates RDRP fidelity/processivity (which he proposed 
are inversely proportional). RH predicts that excess wild-
type protein will prompt a decrease in fidelity and a resultant 
increase in mutation and vice versa. The idea that mutation 
rates may be dependent on polymerization rates was first 
proposed in the kinetic proofreading hypothesis, in which 
a delay in the rate of polymerization results in increased 
polymerase fidelity; experimental support for this has been 
demonstrated in the case of VSV.11,72 While we are of the 
opinion that Sallie’s theory has significant merit, we feel that 
the theory of RH could be further adapted to more accurately 
describe the behavior of HCV.
A framework for the action  
of a variable fidelity polymerase
On the basis of the position of the quasispecies within the 
fitness landscape, we propose that a framework exists for 
the selection of phase-specific mutation rates (Figure 3). 
The RDRP acts along a fidelity spectrum with optimal 
mutation rates that are largely dependent on population size, 
capacity for adaption (adaptive quotient), and  variability of 
Viral load
Beneficial:deleterious
mutations
Mutation rate
Clonal interference
Immune pressure
A B C
Figure 3 Phase diagram demonstrating the proposed behavior of hepatitis C (HCV) 
variable fidelity polymerase. (A) New infection is characterized by an increase in 
the ratio of beneficial:deleterious mutations. HCV polymerases with increased 
mutation rates are selected, promoting exploration of the sequence space, which 
results in viral load spike. (B) Once the sequence space is explored, the ratio of 
beneficial:deleterious mutations decreases and the polymerase mutation rate 
returns to baseline. As the quasispecies expands, clonal interference emerges. 
The advent of host immune response, in combination with reduced mutation, is 
associated with a marked reduction in viral load. (C) Immune-mediated dynamic 
changes in the fitness landscape result in oscillation of clonal interference, viral load, 
and polymerase mutation rates.
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the environment.73,74 We propose that the optimal  mutation 
rate selected for could be predicted by the position of the 
sequence within a framework similar to that proposed 
by Johnson and Barton.52 The exploration of this fidelity 
 spectrum is likely to be initially stochastic, as it is reliant on 
the generation of promutator mutations and evidence for simi-
lar processes can be seen in Drosophila populations.52,75
Following the bottleneck of transmission, unencumbered 
by clonal interference, and with an increased probability 
of beneficial mutations, we suggest that a form of density-
dependent selection, similar to those that have been described 
in foot-and-mouth disease virus, E. coli, and Drosophila, will 
result in the emergence of an increased mutation rate.75–77 
This latter occurrence would be characterized by quicker 
adaptation, could correspond to the intermediate fidelity 
phase as described by Saakian et al, and could be likened to 
the episodes of stress which have also been shown to result 
in increased mutation rates in E. coli.47,78 As the relative pro-
portion of beneficial to deleterious mutations is increased in 
small nonadapted populations, the emergence of an increased 
mutation rate is favored. Initial infection with a finite number 
of variants will gradually explore local fitness maxima by 
stochastic means until the population becomes sufficient 
for deterministic exploration as the capacity to generate all 
possible mutants is achieved.46 With population expansion, 
increasing clonal interference, and viral adaptation, the 
same process will select a less-productive polymerase with 
increased fidelity that has the added potential bonus of being 
immunologically stealthy by means of viral-load reduction. 
This period of selection may result in the reduction in viral 
load often seen in acute HCV.70
Furthermore, increased fidelity will inevitably mean 
that antigenic thresholds will be intermittently breached, 
resulting in activation of the adaptive immune response. As 
the exploration of both sequence space and what we refer to 
as the “fidelity spectrum” is stochastic, it is to some degree 
dependent on chance, but the near certainty of successful 
exploration has been in built into the quasispecies charac-
teristics of the virus. Conversely, the certainty of failure, in 
some cases, to either optimize fidelity or even find infidelity 
sufficient to evade the immune response, provides the tanta-
lizing prospect of explaining the process by which infection 
is cleared in 15%–25% of patients.79,80 The emergence of a 
population selection–mutation equilibrium will tend toward 
a lower mutation rate, as the genetic distance to the nearest 
beneficial mutations is likely to become larger due to this 
adaptation. In summary, at times of stress, the polymerase 
and its inherent mutation rate becomes the unit of selection, 
while, at other times, it is the genomic properties and their 
cooperative/competitive interactions that become the traits 
selected for or against.
In our model, similar to that of RH, the selection of 
particular sequences for removal by the immune system 
will merely result in the generation of new quasispecies to 
match the new fitness landscape, while also facilitating long-
term stability of quasispecies in the absence of variations in 
effective immune pressure. This model also has the capacity 
to explain HCV clearance in the absence of seroconversion, 
as it allows for the attainment of error catastrophe without 
the need for immune response. Additionally, our proposed 
mechanism of action along a fidelity spectrum more coher-
ently explains why the emergence of a single dominant 
quasispecies in the treatment of HCV infection and a low 
rate of quasispecies evolution are more likely to result in 
clearance as opposed to the generation of new quasispecies, 
as Sallie’s model would suggest.69–71
In proposing this model, we must acknowledge that 
one of the major obstacles to clarifying the interaction 
between quasispecies theory and experimental results in 
HCV is the phenomenon of founder effect at the level of 
the individual cell. The prevention of superinfection, in 
theory, means that the apparatus of the cell is at the mercy 
of this sole founder and that competition is prevented, 
promoting the preservation of the status quo. This, coupled 
with evidence demonstrating the prevention of infection 
of neighboring cells via the apical cell membrane and the 
facilitation of virion transfer to these neighbors via tight 
junctions, is equivalent to dynasty building – that is, clonal 
expansion. Accounting for these factors in evolutionary 
models is challenging, particularly when little is known 
of the incidence of superinfection in the context of fitter 
“pilgrim” virions, which may facilitate the conversion of 
the quasispecies to new fitness optima.
Finally, we would like to note one conundrum reconcil-
ing the current theories of optimal mutation rates and the 
suggestion that organisms adapt toward neutral networks. 
Under the survival of the flattest hypothesis, the emergence 
of such fitness landscapes results in a reduction in the rug-
gedness of the fitness landscape. As the number and selective 
power of potentially deleterious mutations are reduced, we 
should see closer optimization of mutation rates to maximize 
 adaptation. However, little evidence has been produced to 
favor this and, conversely, the mutation rate in E. Coli, which 
has a 90% tolerance of mutations, has a mutation rate far less 
than that of RNA viruses, which have a lethal mutation rate 
of 21%–40%.39,81
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Conclusion
Adaptive evolution is slave to both genetic drift and natural 
selection, with the emergence of more neutral flatter fitness 
landscapes favoring the former. Following a bottleneck, 
the exploration of the sequence space is stochastic, with 
the transition to deterministic exploration dependent on the 
population size and the development of clonal interference. 
Mutation rates often fail to optimize adaptation and this may 
be an effort to mitigate the relative strength of lethal mutations 
when compared with the relative and often-marginal benefit 
of beneficial  mutations – particularly, in well-already-adapted 
species.  Mutation rates are not constant and, in low popula-
tion sizes, increased mutation rates may be selected for to 
enhance the rate of adaptation. Several potential mechanisms 
for regulating mutation rates to ensure that these increases are 
transient have been proposed. HCV demonstrates character-
istics consistent with a population density-mediated selection 
of mutation rates.
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